When does a therapeutic intervention beWhen does a therapeutic intervention become an accepted part of standard clinical come an accepted part of standard clinical practice? Is it when there is sufficient repractice? Is it when there is sufficient research evidence? But what constitutes 'sufsearch evidence? But what constitutes 'sufficient'? What about available resources ficient'? What about available resources and acceptability to patients? Do we have and acceptability to patients? Do we have to wait until the National Institute for Clinto wait until the National Institute for Clinical Excellence pronounces? A convincing ical Excellence pronounces? A convincing evidence base for family work in schizoevidence base for family work in schizophrenia (Kuipers, 2000) has existed for phrenia (Kuipers, 2000) has existed for many years but has been poorly implemenmany years but has been poorly implemented . Will ted . Will cognitive-behavioural therapy (CBT) for cognitive-behavioural therapy (CBT) for psychosis suffer the same fate? Which propsychosis suffer the same fate? Which professional group will champion such an fessional group will champion such an implementation? The evidence for other implementation? The evidence for other psychological treatments is less robust. Psypsychological treatments is less robust. Psychoeducation may prolong time to relapse choeducation may prolong time to relapse and improve insight but at the cost of and improve insight but at the cost of increasing suicidal ideation (Carroll increasing suicidal ideation (Carroll et al et al, , 1998) . Personal therapy (Hogarty 1998) Over the past decade CBT for schizoOver the past decade CBT for schizophrenia has received a great deal of phrenia has received a great deal of research attention. Recent reviews of its research attention. Recent reviews of its 1998) and also appear to , 1998) and also appear to translate to clinical practice (Turkington translate to clinical practice (Turkington et al et al, 2002) . Benefits have been demon-, 2002) . Benefits have been demonstrated predominantly for residual sympstrated predominantly for residual symptoms in adult community patients toms in adult community patients receiving an average of 20 sessions over 9 receiving an average of 20 sessions over 9 months, with follow-up 3-9 months later. months, with follow-up 3-9 months later. The evidence does not yet support the The evidence does not yet support the implementation of CBT in relation to proimplementation of CBT in relation to prodromes, first-episode schizophrenia, acute dromes, first-episode schizophrenia, acute relapse, forensic patients with psychosis or relapse, forensic patients with psychosis or those with comorbidity such as substance those with comorbidity such as substance misuse, personality disorder or learning dismisuse, personality disorder or learning disability, nor for psychosis in adolescence and ability, nor for psychosis in adolescence and old age. old age.
A SPECIFIC EFFECT OF CBT? A SPECIFIC EFFECT OF CBT ?
Does CBT really provide added value when Does CBT really provide added value when compared with other non-specific psychocompared with other non-specific psychological interventions? Dickerson (2000) exlogical interventions? Dickerson (2000) examined 20 studies of CBT in schizophrenia amined 20 studies of CBT in schizophrenia and concluded that the effects of CBT were and concluded that the effects of CBT were less apparent when compared with a psyless apparent when compared with a psychological treatment that controlled for chological treatment that controlled for therapy time. A major criticism of CBT retherapy time. A major criticism of CBT research in this area to date has been that the search in this area to date has been that the studies have all employed inadequately destudies have all employed inadequately delivered psychological treatments for comlivered psychological treatments for comparison. Investigator allegiance is also an parison. Investigator allegiance is also an issue in that the supportive therapy and beissue in that the supportive therapy and befriending was not delivered by experts in friending was not delivered by experts in that particular therapy modality but by that particular therapy modality but by cognitive therapists (Paley & Shapiro, cognitive therapists (Paley & Shapiro, 2002) . In this way the non-specific factors 2002). In this way the non-specific factors were well controlled for but the quality of were well controlled for but the quality of the control intervention could be improved the control intervention could be improved further. A clearer understanding of the relafurther. A clearer understanding of the relative efficacy of CBT in schizophrenia will tive efficacy of CBT in schizophrenia will be apparent when it is compared with exbe apparent when it is compared with expert delivery of, for example, interpersonal pert delivery of, for example, interpersonal therapy. It does seem that by short-term therapy. It does seem that by short-term follow-up a clear and specific effect is follow-up a clear and specific effect is apparent with CBT. apparent with CBT.
CONSIDER ATIONS FOR CONSIDER ATIONS FOR FURTHER RESEARCH FURTHER RESEARCH
Research needs to be explicit about Research needs to be explicit about patients' presentations and histories, the patients' presentations and histories, the specific CBT intervention used, the experspecific CBT intervention used, the expertise of the therapists and, most importantly, tise of the therapists and, most importantly, comparator group characteristics and intercomparator group characteristics and interventions. Schizophrenia as a diagnosis pulls ventions. Schizophrenia as a diagnosis pulls together a group of people who vary contogether a group of people who vary considerably in symptom presentation and siderably in symptom presentation and course, number of hospital admissions, course, number of hospital admissions, self-esteem, depression, suicidality, social/ self-esteem, depression, suicidality, social/ family support, response to medication, family support, response to medication, etc. Cognitive-behavioural therapy as a deetc. Cognitive-behavioural therapy as a descriptor is similarly imprecise. At present scriptor is similarly imprecise. At present the label is applied to a wide range of interthe label is applied to a wide range of interventions, ranging from a few sessions of ventions, ranging from a few sessions of support and psychoeducation, through spesupport and psychoeducation, through specific interventions for individual symptoms, cific interventions for individual symptoms, to therapies that last 20-50 sessions and to therapies that last 20-50 sessions and claim to be weakening not only the full claim to be weakening not only the full range of positive and negative symptoms range of positive and negative symptoms but also enduring models of self (schemata). but also enduring models of self (schemata). Therapy might be delivered individually or Therapy might be delivered individually or in groups. Then there are therapists themin groups. Then there are therapists themselves: trials are not always using therapists selves: trials are not always using therapists who are accredited cognitive-behavioural who are accredited cognitive-behavioural therapists, let alone those who are accretherapists, let alone those who are accredited and practised with psychosis. What dited and practised with psychosis. What this points to is that there is no one CBT this points to is that there is no one CBT for schizophrenia. Rather, there are a range for schizophrenia. Rather, there are a range of CBT therapies, some with different unof CBT therapies, some with different underlying theoretical models, offered to a diderlying theoretical models, offered to a diverse group of patients by therapists who verse group of patients by therapists who vary in ability and experience. Beyond this, vary in ability and experience. Beyond this, one way forward is for researchers to be one way forward is for researchers to be concerned not only with the effectiveness concerned not only with the effectiveness of 'CBT for schizophrenia' but also with of 'CBT for schizophrenia' but also with addressing more specific questions. What addressing more specific questions. What are the common, defining hallmarks of are the common, defining hallmarks of any CBT for psychosis? What are the active any CBT for psychosis? What are the active ingredients? Case formulation, for examingredients? Case formulation, for example, is frequently described as crucial to ple, is frequently described as crucial to CBT for psychosis, but there is no empirical CBT for psychosis, but there is no empirical evidence to support this claim (Chadwick evidence to support this claim (Chadwick et al et al, 2003) . Encouragingly, research is be-, 2003) . Encouragingly, research is beginning to address applications of exciting ginning to address applications of exciting new cognitive theoretical models (Gumley new cognitive theoretical models (Gumley et al et al, 1999; Garety , 1999; Garety et al et al, 2001 ). Pragmatic , 2001 ). Pragmatic trials with process measures will allow trials with process measures will allow further clarification of the crucial elements further clarification of the crucial elements of CBT for psychosis in clinical practice. of CBT for psychosis in clinical practice. Also, attempts are being made to clearly deAlso, attempts are being made to clearly describe patients and to use qualitative methscribe patients and to use qualitative methods to assess more of the patient's own ods to assess more of the patient's own experience of psychosis and of therapy. experience of psychosis and of therapy.
IS PR ACTICE RUNNING IS PR ACTICE RUNNING AHEAD OF EVIDENCE ? AHEAD OF EVIDENCE ?
Cognitive-behavioural therapy for schizoCognitive-behavioural therapy for schizophrenia is increasingly being included in phrenia is increasingly being included in the basic training of psychiatrists, psycholothe basic training of psychiatrists, psychologists and nurses. Certainly, policy has not gists and nurses. Certainly, policy has not been slow to endorse it with inclusion in been slow to endorse it with inclusion in the National Health Service Psychotherapy the National Health Service Psychotherapy Review (NHS Executive, 1996) and the Review (NHS Executive, 1996) and the National Service Framework for Mental National Service Framework for Mental Health (Department of Health, 1999) . It Health (Department of Health, 1999) . It has now been taken up internationally, has now been taken up internationally, 9 8 9 8
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with studies and reviews published from with studies and reviews published from Malaysia, Holland, Scandinavia and North Malaysia, Holland, Scandinavia and North America, but is this enough to lead to its America, but is this enough to lead to its formal acceptance? A recent update by the formal acceptance? A recent update by the Cochrane Collaboration of their review of Cochrane Collaboration of their review of CBT in schizophrenia (Cormac CBT in schizophrenia concluded that it was a promising 2002) concluded that it was a promising but underresearched intervention and not but underresearched intervention and not yet recommended for clinical practice yet recommended for clinical practice (although one of the authors declared that (although one of the authors declared that he uses it in his clinical practice). The he uses it in his clinical practice). The American Psychiatric Association has yet American Psychiatric Association has yet to update its schizophrenia guidelines that to update its schizophrenia guidelines that concluded similarly, although this was concluded similarly, although this was prior to the recent publication of more defiprior to the recent publication of more definitive studies. Protocols for research need nitive studies. Protocols for research need to be tightened significantly in relation to to be tightened significantly in relation to valid comparator treatments, therapy defivalid comparator treatments, therapy definition and fidelity, protection of blinding nition and fidelity, protection of blinding of raters and long-term follow-up. Despite of raters and long-term follow-up. Despite these provisos, there is now strong evidence these provisos, there is now strong evidence and clinical support for the implementation and clinical support for the implementation of CBT as part of the standard management of CBT as part of the standard management of patients with residual symptoms of of patients with residual symptoms of schizophrenia. It is time for it to be used schizophrenia. It is time for it to be used to begin to fill a therapeutic vacuum that to begin to fill a therapeutic vacuum that is currently causing patients to experience is currently causing patients to experience unnecessary distress and disability. unnecessary distress and disability.
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